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Abstract
Epistasis plays a significant role in the genetic architecture of many complex phenotypes in model organisms. To date, there have been very few interactions replicated in human studies due in part to the multiple hypothesis burden implicit in genome-wide tests of epistasis.
Therefore, it is of paramount importance to develop the most powerful tests possible for detecting interactions. In this work we develop a new gene-gene interaction test for use in trio studies called the trio correlation (TC) test. The TC test computes the expected joint distribution of marker pairs in offspring conditional on parental genotypes. This distribution is then incorporated into a standard one degree of freedom correlation test of interaction.
We show via extensive simulations that our test substantially outperforms existing tests of interaction in trio studies. The gain in power under standard models of phenotype is large, with previous tests requiring more than twice the number of trios to obtain the power of our test. We also demonstrate a bias in a previous trio interaction test and identify its origin. We conclude that the TC test shows improved power to identify interactions in existing, as well as emerging, trio association studies. The method is publicly available at www.github.com/BrunildaBalliu/TrioEpi. INTRODUCTION Genetic association studies, especially in humans, have focused primarily on marginal effects of genetic variants. While this approach has successfully identified thousands of variants associated with hundreds of complex human diseases (Hindorff et al. 2009 ), it ignores the role of epistasis in shaping phenotypes. Recent work in model organisms has shown that epistasis is a major contributor to broad sense heritability (Ayroles et al. 2009; Bloom et al. 2013 ; Ackermann and Beyer 2012) and interactions have been repeatedly posited as a key component of missing heritability in humans (Zuk et al. 2012; Gibson 2012) . Furthermore, identification of epistatic interactions provides important insights into the functional organization of molecular pathways (Carlborg and Haley 2004; Brem et al. 2005; Cordell 2009; Ayroles et al. 2009; Ma et al. 2012; Ma et al. 2012; Ma et al. 2013 ).
One of the major obstacles in the identification of interactions in genetic association studies is the multiple hypothesis correction penalty induced by the examination of millions of pairs of SNPs. Therefore, it is of fundamental importance to develop the most powerful possible test statistic when searching for interactions. In this work we are concerned with tests for epistasis in trio studies in which mother-father-offspring trios are genotyped and the offspring is a carrier for the disease of interest, or the phenotype of interest is fitness.
There currently exist three classes of test for interaction between pairs of markers in trio studies. First, case-only correlation tests have been proposed where the null hypothesis is no correlation between genotypes at the two loci. While these can easily be performed via χ 2 tests of independence between genotypes, they fail to leverage the information available from the parents in the trios and are susceptible to inflation from population structure.
Second, pseudo-controls can be created via the non-transmitted parental alleles and used as matched controls in a conditional logistic regression framework (Cordell 2002; Cordell et al. 2004; Schwender et al. 2013) . These tests account for population stratification that can induce long range LD between marker pairs and bias the case-only correlation tests. The rest of the paper is organized as follows. In Section 2, we introduce the existing tests and our proposed TC test. In Section 3, we evaluate the finite sample performance of the existing and proposed tests using an extensive simulation study. We close with a discussion in Section 4.
METHODS
Consider a trio study in which n mother-father-offspring trios are genotyped, and the offspring are carriers for the disease of interest, or the phenotype of interest is fitness. In this section we present existing tests for detecting interaction between pairs of markers as well as our novel TC approach.
The Standard Independence (SI) Test Consider a pair of bi-allelic markers with possible genotypes g 1 , g 2 ∈ {0, 1, 2}. Let O(g 1 , g 2 ) the observed counts for the nine possible genotype combinations at these two markers in the offspring. Further, let O(g 1 ) = g 2 O(g 1 , g 2 ) and O(g 2 ) = g 1 O(g 1 , g 2 ) the observed marginal counts of the three possible genotypes at each marker. Last, let E(g 1 , g 2 ) the expected counts of all nine possible genotype combinations at the two markers, as computed from the products of the observed marginal counts at each marker. That is E(g 1 , g 2 ) = O(g 1 ) × O(g 2 )/n.
A χ 2 test statistic can be obtained by first calculating the squared difference of observed and expected counts for each genotype combination of the two markers divided by the corresponding expected counts. The final score for a marker pair is the sum of these values over all nine possible genotype combinations,
Under the null hypothesis of marker independence, SI is assumed to be asymptotically χ 2 4 distributed.
The Imbalanced Allele Pair Frequencies (ImAP) Test Ackermann and Beyer (2012) proposed to calculate the expected counts in the children using the parental genotypes and the laws of Mendelian inheritance. Under Mendelian segregation, the offspring inherits alleles randomly from its parents and the expected genotype of each marker can be derived from the genotypes of the parents. The resulting probabilities for all possible parental genotype combinations are shown in Table 1 .
[ Let G m i ,G f i , G c i the genotypes of the mother, father and child of trio i at a marker.
Moreover, let
the probability of the offspring having genotype g 1 conditional on the parental genotypes, as calculated using the probabilities in Table 1 . For example, if G c i = 1, G m i = 1 and G f i = 2 then P i (0) = .25, P i (1) = .5, P i (2) = .25.
If the offspring are selected based on a phenotypic designation such as disease status, then a SNP increasing risk for the disease will be non-randomly inherited by the offspring. In order to correct for such main effects Ackermann and Beyer (2012) proposed to multiply each offspring's expected genotype by the ratio of the sample-wide observed and expected counts for the corresponding marker, that is
.
(3)
The above computation of P i (g 1 ) does not guarantee that g 1 P i (g 1 ) = 1. Ackermann and Beyer (2012) proposed to use the following normalization:
Subsequently, the expected counts of each genotype combination using the adjusted for main effects and normalized genotype counts can be calculated as
The corresponding ImAP statistic is given as,
Because this χ 2 -like test statistic is not properly calibrated under the null hypothesis, Ackermann and Beyer (2012) assess the significance via a permutation approach. ImAP is nearly χ 2 4 distributed and we use this approximation to compute p-values in addition to the permutation approach. However, we show in Section 3 that in the presence of main effects the ImAP test statistic is inflated, even when the permutation approach is used to compute the p-values. The source of this inflation is the normalization step (4) (see Supplementary   Text ).
The Standard Correlation (SC) Test Let µ 1 = g 1 ∈{0,1,2} g 1 × O(g 1 )/n the expected value of the genotype at a marker and let σ 1 2 = g 1 ∈{0,1,2}
2 )/n the covariance of genotypes at the two markers and ρ = σ 12 / √ σ 1 2 σ 2 2 their Pearson's correlation coefficient.
The test statistic is given as
Under the null hypothesis, SC is assumed to be asymptotically χ 2 1 distributed.
The Trio Correlation (TC) Test Let E p (g 1 ) = n i=1 P i (g 1 ) the expected genotype counts of genotypes at each of the two markers in the pair, computed based on the un-adjusted for main effects and un-normalized conditional genotype counts of the offspring in (2). In order to extend the standard correlation test based on the Pearson's correlation coefficient such that information from parental genotypes is incorporated, we propose to compute µ 1 and µ 2 from the expected counts E p (g 1 ) and E p (g 2 ), rather than the observed genotype counts O(g 1 ) and O(g 2 ).
Let µ * 1 = g 1 ∈{0,1,2} g 1 ×E p (g 1 )/n the new expected value and σ *
covariance and ρ * = σ * 12 / σ * 1 2 σ * 2 2 the new correlation coefficient. Then the TC test statistic is given as
Under the null hypothesis, T C is assumed to be asymptotically χ 2 1 distributed. Unlike the ImAP test we do not utilize the normalized conditional probabilities and so we do not suffer from this source of inflation. In this work we use additive marginal effects for both SNPs. The p-values can be computed by approximation to a χ 2 distribution with one d.f. We refer to this test as CLRP C 2 .
Conditional Logistic Regression with
In this work we use the R (R Core Team 2014) implementation of these tests available in the R package trio (Schwender et al. 2013) at http://cran.r-project.org.
SIMULATION STUDY
Data Generation To evaluate the relative performance of the tests described in the previous section in terms of type I error rate and power, we performed a series of simulation studies under a liability threshold model of disease. Using random mating and Hardy-Weinberg Equilibrium assumptions we generated genotypes at two markers, each with a minor allele frequencies of 0.5, for a random sample of N trios, with N =10K, 50K and 100K. To generate y i , the liability of offspring i, we used the following regression model:
where β 1 and β 2 are the main effects of each marker and γ is their interaction effect, i ∼ N (0, σ 2 ) a random error term with variance σ 2 chosen such that both markers explain 10% of the heritability of the liability. This large effect size is used to test for inflation of interaction tests under main effects only models of phenotype.
In order to study the impact of ascertainment and disease prevalence in the performance of the tests, we selected from the initial random sample of N trios the 1,000 offspring with the highest phenotype values and their parents. The higher the value of N , the stronger the ascertainment is and the lower the disease prevalence is, since the sample of 1,000 trios represents a smaller fraction of the initial sample.
For each choice of parameters 10,000 data sets were generated and we applied the SI, ImAP, SC, TC, as well as the two CLRPC tests to each data set. We also examined the ImAP test without the normalization step (4), which we refer to as ImAP 2 . The ImAP 2 test statistic is computed as the ImAP test statistic in (5) but the expected counts of each genotype combination are computed using the product of the adjusted for main effects only genotype counts P , as opposed to the product of the adjusted for main effects and normalized counts P * used for ImAP . The reason we show results for ImAP 2 is to present the source of bias in the ImAP test, i.e. the normalization step in (4).
In addition, we also examined the ImAP test without the adjustment for main effects
(3) and without the normalization step (4), which we refer to as ImAP 3 . Similarly to the ImAP 2 test statistic, the ImAP 3 is computed as the ImAP test statistic in (5) but now the expected counts of each genotype combination are computed using the product of P , i.e. the genotype counts without main effect adjustment or normalization. Results for ImAP 3 are presented in order to study the impact of main effect adjustment when main effects are not present.
Results on Type I Error Rate
We first examined the type I error rate performance of the tests under the null hypothesis of no main effects and no interaction effects (β 1 =β 2 =γ=0).
The results in Table 2 .a show that all tests with the exception of the ImAP tests are well calibrated, with an average χ 2 test statistic equal to the d.f. of the test. We then examined the robustness of the tests when main effects, but no interaction effects exist (β 1 =β 2 =0.1 and γ=0). The results displayed in Table 2 .b show that all tests suffered some degree of inflation. This inflation is driven by the fact that marginally associated SNPs will become correlated in ascertained data (Zaitlen et al. 2012; Zaitlen et al. 2012) . Ascertainment based inflation will increase as the disease prevalence decreases.
Interestingly, the TC test is the least biased of these tests for the highest prevalence disease and the most biased for the lowest prevalence disease. This known source of bias is relatively minor compared to the genome-wide testing threshold and therefore unlikely to result in false-positive interaction results. However, the ImAP test is severely inflated under this marginal effects only model and is very likely to produce false positives. As noted in the previous section, this inflation is driven by the normalization procedure as evidenced by the fact that without normalization (ImAP 2 ), the test is similar to the other tests considered.
[ [ Table 3 about here.]
Population structure can induce correlation between distant SNPs. In order to examine the effects of structure on the interaction tests we performed another a set of simulations in a pseudo-admixed population. We assumed minor allele frequencies of 0.5 and 0.1 in populations one and two respectively. For each mother and father we drew genome-wide ancestry uniformly on the interval [0.1,0.9]. We then drew local ancestry from a binomial according to the genome-wide ancestry. Finally, we drew genotypes based on the minor allele frequencies for each population conditional on the local ancestry at each SNP. The rest of the simulation proceeded as above.
The results of the pseudo-admixed population simulations under the null hypothesis of no interaction effect are presented in Table 4 . As expected all interactions tests are inflated in structured populations. However, the CLRPC test is less inflated than all others and is therefore the recommended test when dealing with structured populations.
[ Ackermann and Beyer (2012) showed that in the absence of main effects the significance of the ImAP test statistic for each marker pair can be properly assessed via a permutation approach. We showed here that the permutation approach used to calibrate the ImAP test statistic in the absence of main effects will not address the inflation caused in the presence of main effects. We identify as a source of inflation the normalization step in (4), which alters the correlation structure of the expected genotype probabilities and introduces bias in the test statistic.
All methods considered here will be slightly inflated due to ascertainment for low prevalence diseases. However, this inflation is minimal and not enough to pass a genome-wide significance threshold. There has been a renewed interest in trio cohorts with affected offspring for the purposes of identifying denovo mutations and parent of origin effects (O'Roak et al. 2011; Arjomandi et al. 2011; O'Roak et al. 2012; Neale et al. 2012; Sanders et al. 2012) . While these collections have identified many denovo mutations, they have not yet been examined for the presence of interactions and our test is therefore of immediate benefit to these rapidly growing trio cohorts.
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SUPPLEMENTARY TEXT
Let p 0 = [p 1 (0), . . . , p n (0)], p 1 = [p 1 (1), . . . , p n (1)], and p 2 = [p 1 (2), . . . , p n (2)] vectors of the expected probability of genotypes 0, 1, and 2 for all offspring at a marker as calculated using the probabilities in Table 1 and let R =
be the matrix of pairwise correlations between p 0 , p 1 , and p 2 . Similarly, let p 0 , p 1 , and p 2 the vectors of the expected probabilities after main effects adjustment in (3), with R their correlation matrix; and p * 0 , p * 1 , and p * 2 the vectors of expected probabilities after main effects adjustment and normalization in (4), with R * their correlation matrix.
We showed in Section 3 that under the null hypothesis of no interaction effect but presence of main effects the ImAP tests statistic is inflated. We also showed that the ImAP permutation procedure does not address this inflation. Since ImAP 2 , the test without the normalization step, is not inflated under this scenario, we concluded that the normalization of the expected genotype probabilities in 4 is causing the inflation. We mention in the previous section that, in the presence of main effects, the normalization in (4) alters the correlation of the genotype probabilities used to compute the expected joint distribution of the markers in the cases but not in the pseudo-controls. To illustrate this, we compare the R, R and R * matrices of the cases and pseudo-controls generated under the null hypothesis of no interaction and main effects, i.e. γ = β 1 = β 2 = 0, with the matrices for the cases and the pseudo-controls under the null hypothesis of no interaction effect, i.e. γ = 0, and presence of main effects, i.e. β 1 = β 2 = .1. These matrices are listed in Table 7 .
In the absence of main effects R = R and R ≈ R * (Table 7 .a). On the other hand, in the presence of main effects the two matrices are similar for the pseudo-controls but are very different for the cases. The largest difference being between ρ ( p 1 , p 0 ) and ρ ( p * 1 , p * 0 ), correlation of −0.240 before normalization and −0.135 after normalization, and between ρ ( p 1 , p 2 ) and ρ ( p * 1 , p * 2 ), correlation of −0.633 before normalization and −0.719 after normalization.
[ Table 7 : Correlation matrices of the expected genotype probabilities R (first column), the expected genotype probabilities after adjustment for main effects R (second column), and the expected genotype probabilities after adjustment for main effects and normalization R * (second column). Results are based on mean over 10,000 simulated data sets. PC, pseudocontrols.
